RESTATED AND AMENDED LICENSE AGREEMENTLicense Agreement • March 2nd, 2015 • Aduro Biotech, Inc. • Pharmaceutical preparations • Maryland
This Restated and Amended License Agreement (“Restated and Amended Agreement”, JHU Ref. No. A18558) is made as of the EFFECTIVE DATE by and between The Johns Hopkins University, a corporation of the State of Maryland, having a principal place of business at 3400 N. Charles St., Baltimore, MD 21218 (hereinafter referred to as “JHU”) and BioSante Pharmaceuticals, Inc, a Delaware corporation (hereinafter referred to as “Company”), having an address at 111 Barclay Boulevard, Suite 280, Lincolnshire, IL 60069.
LICENSE AGREEMENTLicense Agreement • March 2nd, 2015 • Aduro Biotech, Inc. • Pharmaceutical preparations • California
This License Agreement (this “Agreement”) is made effective as of June 20, 2012 (the “Effective Date”) by and between Karagen Pharmaceuticals, Inc., a Maryland close corporation with a principal place of business at 4 Club Road, Baltimore, Maryland 21210 (“Licensor”), and Aduro BioTech, Inc. (“Licensee”), a Delaware corporation with a place of business at 626 Bancroft Way, Berkeley, CA 94710. Licensor and Licensee are each hereafter referred to individually as a “Party” and together as the “Parties”.
MANUFACTURING SERVICES AGREEMENTManufacturing Services Agreement • March 2nd, 2015 • Aduro Biotech, Inc. • Pharmaceutical preparations • New York
This Manufacturing Services Agreement (this “Agreement”) is made as of August 6, 2013, (the “Effective Date”) between Lonza Walkersville, Inc., a Delaware corporation having its principal place of business at 8830 Biggs Ford Road, Walkersville, Maryland 21793 (“LWI”), and Aduro BioTech, Inc., a Delaware corporation located at 626 Bancroft Way, 3C, Berkeley, CA 94710-2224 (“CLIENT”) (each of LWI and CLIENT, a “Party” and, collectively, the “Parties”).
ADURO BIOTECH, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT December 19, 2014Investor Rights Agreement • March 2nd, 2015 • Aduro Biotech, Inc. • Pharmaceutical preparations • Delaware
This Agreement dated as of December 19, 2014 is entered into by and among Aduro Biotech, Inc., a Delaware corporation (the “Company”), and the individuals and entities listed on Exhibit A attached hereto (the “Purchasers”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 2nd, 2015 • Aduro Biotech, Inc. • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”) is made effective as of January 31, 2013 (the “Effective Date”) by and between BioSante Pharmaceuticals, Inc. a Delaware corporation with a principal place of business at 111 Barclay Boulevard, Suite 400, Lincolnshire, Illinois 60069 (“Seller”), and Aduro GVAX Inc., a Delaware corporation with a principal place of business at 626 Bancroft Way, #3C, Berkeley, CA 94710-2224 (“Buyer”). Seller and Buyer are each hereafter referred to individually as a “Party” and together as the “Parties”.
PATENT AND TECHNOLOGY LICENSE AND MATERIALS TRANSFER AGREEMENT BY AND BETWEEN THE JOHNS HOPKINS UNIVERSITY ADURO BIOTECH, INC. JHU Agreement: # -A21083Patent and Technology License and Materials Transfer Agreement • March 2nd, 2015 • Aduro Biotech, Inc. • Pharmaceutical preparations • Maryland
THIS PATENT AND TECHNOLOGY LICENSE AND MATERIALS TRANSFER AGREEMENT (this “Agreement”) is dated as of January 31, 2013 (the “Effective Date”) and entered into by and between THE JOHNS HOPKINS UNIVERSITY, a Maryland corporation having an address at 3400 N. Charles Street, Baltimore, Maryland, 21218-2695 (“JHU”) and ADURO BIOTECH, INC., a Delaware corporation having an address at 626 Bancroft Way, Suite 3C, Berkeley, California 94710-2225 (“Company”):
